Published
August 08, 2025
The U.S. Chamber of Commerce is leading the charge against harmful price control policies. Price controls threaten to undermine the innovation ecosystem that has made the United States a global leader in medical advancements. Our research reveals that such policies deter investment in life-saving treatments, delay patient access to new medicines, and jeopardize the development of groundbreaking cures for chronic and life-threatening diseases. We are committed to protecting American patients and ensuring they continue to benefit from the world’s most advanced and accessible healthcare innovations.
Price controls have devastating consequences for patients and the biopharmaceutical industry. Countries with similar policies experience fewer new medicine launches, longer wait times for treatments, and reduced access to innovative medicines. Price controls risk turning America’s innovation oasis into a research desert, with private sector research funding potentially slashed by up to 75%. This decline would disproportionately impact critical areas like cancer, diabetes, and rare diseases, leaving patients without the hope of timely and effective treatments. The Chamber is actively fighting these policies through litigation, advocacy, and public engagement to safeguard the future of medical innovation.
Our advocacy is rooted in the belief that a competitive, market-driven approach is the best way to deliver affordable, life-saving treatments to Americans. We are working tirelessly to educate policymakers and the public on the dangers of government-imposed price controls and to promote solutions that preserve innovation while enhancing patient access and affordability. Together, we can ensure that America remains a global leader in life science innovation, delivering better health outcomes and a brighter future for all. Explore our research, initiatives, and ongoing efforts to protect the health and well-being of American patients.
About the author
Brad Watts
Brad Watts is the Senior Vice President at the U.S. Chamber of Commerce's Global Innovation Policy Center (GIPC). He works with U.S. Chamber members to foster a political, legal, and economic environment where innovators and creators can invest in the next big thing for the benefit of Americans and the world.
